Bowel perforation from bevacizumab for the treatment of metastatic colon cancer: incidence, etiology, and management (Q80257767)
Jump to navigation
Jump to search
scientific article published on 01 September 2006
Language | Label | Description | Also known as |
---|---|---|---|
English | Bowel perforation from bevacizumab for the treatment of metastatic colon cancer: incidence, etiology, and management |
scientific article published on 01 September 2006 |
Statements
Bowel perforation from bevacizumab for the treatment of metastatic colon cancer: incidence, etiology, and management (English)
John H Heinzerling
1 September 2006